The stress-induced extracytoplasmic sigma factor E (SigE) of Mycobacterium tuberculosis shows increased expression after heat shock, sodium dodecyl sulfate treatment, and oxidative stress, as well as after phagocytosis in macrophages. We report that deletion of sigE results in delayed lethality in mice without a significant reduction of bacterial numbers in lungs.
Mycobacterium tuberculosis encodes 13 sigma factors belonging to the 70 class of factors (3, 8) . SigA and SigB are the principal sigma factors, and the other 11 are alternative sigma factors, with all but SigF considered to be extracytoplasmic function factors, mediating interactions of the bacterium with the extracellular environment. The sigE gene is conserved in mycobacteria but is not essential for growth in vitro (18) . Deletion of sigE (⌬sigE) results in increased susceptibility to heat shock and chemical stress (6, 15, 18) . Expression of sigE increases after phagocytosis by human and mouse macrophages (9, 10) . In the absence of sigE, the viability of M. tuberculosis in both activated and unactivated macrophages is decreased (15) . Finally, deletion of sigE has been shown by microarray analysis to result in the downregulation of genes which encode transcriptional regulators, fatty acid metabolism enzymes, and heat shock proteins (15) .
In our laboratory we have characterized a number of sigma factors in terms of their responses to stress, their effects on the expression of other genes, and their phenotypes in mice (2, 5, 11) . We report here our findings with C3H/HeJ mice infected by aerosol with an M. tuberculosis CDC1551 sigE deletion mutant compared to mice infected with wild-type or sigE-complemented M. tuberculosis CDC1551 (7). Utilizing a targeteddisruption strategy based on the vector pCK0686, which contains a hygromycin resistance cassette flanked by multiple cloning sites (MCS) (11), we cloned a left-flank PCR product with 1,943 bp proximal to the sigE gene (MT1259/Rv1221) and a nonoverlapping right-flank product of 1,889 bp into the MCS, resulting in the deletion of the central region of sigE from the targeting vector. Only 19 bp of the 5Ј end and 392 bp of the 3Ј end of the sigE gene remained in place, while a central 360 bp was deleted. The resulting plasmid, pCK0699, was then used to transform M. tuberculosis CDC1551 in a two-step selection process, with Southern blotting used to confirm allelic exchange. A complemented sigE mutant strain was created by cloning a 2,930-bp M. tuberculosis CDC1551 genomic fragment including the coding region as well as the regulatory region of the sigE gene and 215 bp downstream into an L5 phage-based integration-proficient vector for mycobacteria, pMH94 (12), and then transforming the M. tuberculosis ⌬sigE mutant with this vector. Groups of inbred C3H/HeJ or BALB/c-severe combined immunodeficiency (SCID) mice were infected by aerosol with matched inocula of the wild-type, knockout, or complemented strain, which routinely implant ϳ100 organisms in the lungs. For CFU organ burden determinations, groups of five mice were sacrificed at day 1 and at 4, 12, and 20 weeks and lung and spleen CFU counts were enumerated. For time-todeath studies, groups of 10 mice were infected with matched inocula and monitored daily for mortality.
The M. tuberculosis ⌬sigE mutant showed a CFU organ burden in C3H/HeJ mouse lungs that was similar to the pattern observed with wild-type infection (Fig. 1) . The complemented ⌬sigE mutant gave lung CFU counts that closely matched those of the wild type and the ⌬sigE mutant (log 10 CFU counts at 12 and 16 weeks of 3.67 Ϯ 0.29 and 4.06 Ϯ 0.3, respectively). Spleen counts for C3H/HeJ mice showed that all three strains were absent in the spleens on day 1 following aerosol infection but then disseminated from lungs to the spleen by 4 weeks at equivalent levels (log 10 spleen CFU counts of 3.54 Ϯ 0.83, 2.08 Ϯ 1.9, and 2.33 Ϯ 2.31 for the wild type, ⌬sigE mutant, and complemented ⌬sigE mutant, respectively). Thus CFU organ burden studies of immunocompetent C3H/HeJ mice showed that the M. tuberculosis ⌬sigE mutant and the complemented strain had virulence equivalent to that of the wild-type parental strain, CDC1551.
In contrast, time-to-death analysis showed that 50% of C3H/ HeJ mice infected with wild-type and complemented M. tuberculosis died by days 194 and 236, respectively, whereas 50% of mice infected with the ⌬sigE mutant survived 291 days ( Fig.  2A) . Remarkably, all BALB/c-SCID mice infected with wildtype or complemented bacilli died by day 39 or 47, whereas none of the mice infected with the mutant died until day 70 (Fig. 2B) . Kaplan-Meier analysis showed that times to death for both immunocompetent C3H/HeJ and immunocompromised BALB/c-SCID mice infected with the ⌬sigE mutant were significantly prolonged compared to those for mice infected with the wild-type or complemented strain (P Ͻ 0.001).
In immunocompetent mice, but not immunocompromised mice, the complemented strain exhibited a phenotype intermediate between the wild-type and the knockout phenotypes. The difference in time to death between wild-type and complemented bacilli was statistically significant, suggesting that, as measured in this assay, complementation may have been only partial. Thus, despite achieving a persistent, high-organ-burden infection in mouse lungs, the M. tuberculosis ⌬sigE mutant was found to be significantly attenuated by time-to-death analysis.
We have previously observed a similar virulence phenotype with the M. tuberculosis ⌬sigH mutant, in which high organ CFU counts in both mutant and wild-type bacilli were observed but animals infected with the mutant showed a significant delay in time to death (11) . One distinction from the ⌬sigH mutant is that there is a significant delay in the time to death for SCID mice as well as for immunologically intact mice after infection with the ⌬sigE mutant bacilli. This may suggest that the ⌬sigE tubercle bacilli are more susceptible to innate, T-cell-independent killing than are the ⌬sigH organisms. Interestingly, for the M. tuberculosis ⌬sigH mutant, both CD4 and CD8 cell recruitment to the lung was reduced in mouse tissues at 4 weeks; similarly, histological sections showed a corresponding delay in disease progression in mouse tissues on infection with the ⌬sigH mutant (11). We have designated this phenotype of bacterial persistence with reduced host mortality the immunopathology (imp) defect. Although the immunopathology phenotype has been observed upon mouse infection with both the M. tuberculosis ⌬sigH and now the ⌬sigE mutants, it is significant that functional redundancy does not appear to account for the similar animal phenotypes. Microarray analysis of the M. tuberculosis ⌬sigH mutant suggests that the sigma factor governs a redox stress response regulon, with several thioredoxins and thioredoxin reductases showing relative underexpression in the ⌬sigH mutant compared with expression in the wild type (11) . In contrast, the M. tuberculosis ⌬sigE mutant sigma factor has been reported to govern a more generalized stress response regulon (15) , and inspection of the genes putatively governed by these sigma factors reveals few common genes. Interestingly, the impaired survival of the M. tuberculosis ⌬sigE mutant within macrophages reported by Manganelli et al. (15) does not appear to extend to a survival defect in lung and spleen tissues in C3H/HeJ mice. Recently, several non-sigma factor M. tuberculosis mutants, including the M. tuberculosis ⌬RD1 mutant (13) and ⌬whiB3 mutant (17), have been reported; these mutants show mouse infection patterns similar to the immunopathology phenotype observed in the M. tuberculosis ⌬sigH and ⌬sigE mutants. As both the RD1 region (14) and the whiB-like gene family (4, 16) have been implicated in gene regulation, one might speculate that the immunopathology phenotype is an attenuation pattern associated with aberrant gene regulation pathways and an inability to adapt to key stimuli during growth in vivo in live animal hosts. While further research will be important in order to understand the basis of the immunopathology defect, this class of M. tuberculosis mutants has attractive features as live, attenuated vaccines against tuberculosis in view of their reduced lethality 
